Showing results (811-820 of 972) with videos related to

Sort By:
Pageof 98
Journal of Ethnopharmacology|August 6, 2023
Vitro UPLC analysis and mass method identification, and in vivo or cellular immune anti-inflammatory function of Sanhuang Xiexin Decoction (SHXD)Yang Gao, Shi-Qiao Liu, Jia-Long Wang, et al.
Oncotarget|February 13, 2016
Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathwaysYing-Min Wu, Zhuo-Jia Chen, Guan-Min Jiang, et al.
Technology in Cancer Research & Treatment|May 6, 2021
Continuous Low-Dose Apatinib Combined With WBRT Significantly Reduces Peritumoral Edema and Enhances the Efficacy of Symptomatic Multiple Brain Metastases in NSCLCYue Ren, Shan-Bing Wang, Lin Zhou, et al.
Sexually Transmitted Diseases|October 16, 2012
HIV prevalence varies between female sex workers from different types of venues in southern ChinaXiang-Sheng Chen, Guo-Jun Liang, Qian-Qiu Wang, et al.
Clinical Pharmacology and Therapeutics|May 6, 2025
Gut Microbiota in Patients with Tuberculosis Associated with Different Drug Exposures of Antituberculosis DrugsYue Zhu, Qiao Liu, Jan-Willem Alffenaar, et al.
Iscience|December 4, 2023
Radiomics and dosiomics for predicting radiation-induced hypothyroidism and guiding intensity-modulated radiotherapyShan-Shan Yang, Qing-He Peng, Ai-Qian Wu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|March 6, 2024
EPAC inhibitor suppresses angiogenesis and tumor growth of triple-negative breast cancerZishuo Li, Qiao Liu, Yuhao Cai, et al.
The Lancet Regional Health. Western Pacific|April 10, 2026
Dynamic, quantitative ESAT6-CFP10 skin test for tuberculosis risk prediction: a large-scale, multi-center, prospective cohort studyPeng Lu, Zhongqi Li, Bilin Tao, et al.
Nature Communications|June 5, 2026
Mycobacterium tuberculosis transmission from tuberculosis patients with and without recognized symptoms: a case-contact study in eastern ChinaCheng Chen, Xinsong Hu, C Robert Horsburgh, et al.
Journal for Immunotherapy of Cancer|July 6, 2022
Baseline and post-treatment biomarkers of resistance to anti-PD-1 therapy in acral and mucosal melanoma: an observational studyIrene M Shui, Xiao Qiao Liu, Qing Zhao, et al.
Pageof 98